Table 3. Analysis of the factors predisposing to revision surgery.
Variable | Level | Revision | χ² | P-value | ||
No | Yes | |||||
Gender | Male | Observed | 31 | 14 | 3.04 | 0.081 |
Expected | 34.58 | 10.42 | ||||
Female | Observed | 42 | 8 | |||
Expected | 38.42 | 11.58 | ||||
Periprosthetic infection | No | Observed | 73 | 20 | 6.78 | 0.009* |
Expected | 71.46 | 21.54 | ||||
Yes | Observed | 0 | 2 | |||
Expected | 1.54 | 0.46 | ||||
Periprosthetic fracture | No | Observed | 73 | 20 | 6.78 | 0.009* |
Expected | 71.46 | 21.54 | ||||
Yes | Observed | 0 | 2 | |||
Expected | 1.54 | 0.46 | ||||
Cemented | No | Observed | 49 | 6 | 11.01 | <0.001* |
Expected | 42.26 | 12.74 | ||||
Yes | Observed | 24 | 16 | |||
Expected | 30.74 | 9.26 | ||||
Osteolysis | No | Observed | 69 | 9 | 33.07 | <0.001* |
Expected | 59.94 | 18.06 | ||||
Yes | Observed | 4 | 13 | |||
Expected | 13.06 | 3.94 | ||||
Component lessening | No | Observed | 69 | 4 | 55.36 | <0.001* |
Expected | 56.09 | 16.91 | ||||
Yes | Observed | 4 | 18 | |||
Expected | 16.91 | 5.09 | ||||
Small particle disease | No | Observed | 72 | 18 | 9.58 | <0.001* |
Expected | 69.16 | 20.84 | ||||
Yes | Observed | 1 | 4 | |||
Expected | 3.84 | 1.16 | ||||
Dislocation | No | Observed | 73 | 21 | 3.35 | 0.067 |
Expected | 72.23 | 21.77 | ||||
Yes | Observed | 0 | 1 | |||
Expected | 0.77 | 0.23 | ||||
Thromboembolic events | No | Observed | 73 | 21 | 3.35 | 0.067 |
Expected | 72.23 | 21.77 | ||||
Yes | Observed | 0 | 1 | |||
Expected | 0.77 | 0.23 |